|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||98.75 - 98.75|
|52-week range||88.75 - 108.61|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||8.40|
|Forward dividend & yield||3.86 (3.91%)|
|Ex-dividend date||05 May 2021|
|1y target est||N/A|
The French-based pharmaceutical company Sanofi (NASDAQ: SNY) has been flying under the radar over the past few years as companies like AbbVie, Bristol Myers Squibb, and Merck have dominated the space through the tremendous success of their drugs. Sanofi was actually a creation of several different companies, including Aventis, Synthélabo, Hoechst, Rhône-Poulenc Rorer, and several others. Through mergers and acquisitions (M&A) we got the Sanofi we know today.
Dr. Andre Campbell, Professor of Surgery of UCSF & ICU Physician and Trauma Surgeon at Zuckerberg San Francisco General Hospital, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus pandemic.
Dr. Stella Safo, NYC-based HIV primary care physician, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus pandemic.